Senior Market Access Manager - Alexion - secondment/contract until 30.11.27

AstraZeneca

Greater London

Hybrid

GBP 90,000 - 130,000

Full time

4 days ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Excellent benefits

Job summary

AstraZeneca plc's Senior Market Access Manager role in London leads UK&I market access strategy for rare disease assets, overseeing pricing and HTA submissions across NICE/SMC/NCPE.

You will work with cross-functional teams, engage with national payers, and manage external suppliers to deliver high-quality evidence and compelling pricing cases. The role emphasizes collaboration, strategic thinking, and timely delivery.

Qualifications

  • Demonstrated experience delivering national-level market access in UK & Ireland.
  • Proven ability to create and execute national pricing strategies and secure approvals.
  • Strong external engagement with HTA bodies and payers.
  • Leadership of HTA submissions and management of external suppliers.
  • Experience collaborating with cross-functional teams across functions.

Responsibilities

  • Lead UK/I market access strategy for selected rare disease assets.
  • Co-lead HTA submissions and manage external suppliers.
  • Engage with NICE, ISPOR and other bodies for national submissions.
  • Develop and implement pricing and access strategies to maximise asset value.
  • Collaborate with Health Economics and New Products Planning teams.

Skills

HTA submissions
Pricing strategy
Stakeholder engagement
Cross-functional leadership
Fluent English

Tools

Excel

Job description

Role: Senior Market Access Manager - Alexion - secondment/fixed-term contract until 30.11.27

Location: St Pancras Square London UK

Salary: Competitive + Excellent Benefits

Purpose
  • To lead Pricing and HTA (Health Technology Appraisal) engagements for selected rare disease assets and indications in the UK and Ireland
  • Generates high quality national, regional and local access strategies, evidence submissions and pricing business cases
Key Responsibilities and Accountabilities
Market Access strategy and delivery of HTA submissions (60%)
  • Leads the UK/I Market Access Strategy for selected rare disease assets within assigned disease areas, collaborating with a matrix of global and local stakeholders.
  • Co-Leads with the Health Economics colleague the development of high quality HTA submission or other national submissions, managing external suppliers as required
  • Lead Alexion engagements at product level with national HTA organisations in collaboration with Health Economists, New Products Planning, Medical Affairs and other relevant cross-functional colleagues, including NICE Advice, System engagement meetings etc
  • Subject matter expert on UK market access environment within the UK organisation to technically support development of an optimal HTA strategy
  • Contributes to the development of pipeline asset commercialisation plans, working in collaboration with the New Products Planning lead to develop market access strategies that maximise asset life-cycle value
Pricing Strategy & Process management (20%)
  • Leads UK/I pricing strategy for selected rare disease assets with assigned disease areas, collaborating with a matrix of global and local stakeholders
  • Develops innovative pricing strategies to overcome complex challenges associated with enabling access to medicines for people living with rare diseases
  • Secures pricing business case approvals to enable local access strategy delivery
  • Manages engagements and inputs on commercial access agreements (e.g. PAS, tenders, etc) as required
  • Collaborates with New Product Planning Lead to manage UK Pharmascan entries for AZ pipeline products
External engagement and advocacy with national, regional and local payers (20%)
  • Subject matter expert on access and funding pathways at national and regional levels
  • Engage national/regional/local stakeholders through appropriate processes to improve access environment for Alexion's rare disease portfolio, working with Corporate Affairs.
  • Represents Alexion externally at relevant conferences (NICE Conference, ISPOR) as appropriate to provide access insights and anticipate future opportunities to support business performance.
  • Create a clear understanding of the national context under which the local healthcare organisations operate - taking a future view of the customer landscape and proactively communicating the changing landscape to the business
Essential Requirements
  • Previous demonstrated experience delivering national-level market access in the UK & Ireland within the Pharmaceutical Industry or specialist market access consultancy.
  • Demonstrated ability to create and execute national and regional pricing and access strategies, secure internal pricing business case approvals, and manage commercial access agreements (e.g., PAS).
  • Strong external engagement history with national agencies and payers; effective participation in advice meetings, consultations, and system engagement forums.
  • Proven leadership of HTA submissions (NICE/SMC/AWMSG/NCPE), including co-leading evidence generation with health economists and managing external suppliers; successful outcomes for high-cost, specialised/rare/orphan assets.
  • Experience working with specialised centres, clinical networks, and patient organisations to inform access strategy and evidence positioning.
  • Exceptional project management, leading cross-functional teams to deliver submissions and launch-critical milestones on time
  • Fluent in English with excellent written and verbal communication tailored to technical and executive audiences
  • Strategic Mindset and technical depth: ability to design optimal HTA strategies and pricing/access pathways; understand funding flows and stakeholder dynamics across UK & Ireland.
  • Drives Results and accountability: consistently delivers complex submissions and pricing approvals to plan; sets clear KPIs and manages performance.
  • External influence and network building: engages credibly with HTA bodies, payers, and policy stakeholders; builds relationships that enable timely, positive decisions.
  • Communication excellence: synthesises complex evidence and policy into clear recommendations; writes high-quality submission content and executive briefs
  • Ability to articulate rare disease value propositions, address small-population evidence challenges (e.g., heterogeneity, RWE reliance), and navigate specialised commissioning criteria.
  • Cross-functional leadership: orchestrates multi-disciplinary teams, resolves ambiguities, and drives clarity in a matrixed environment.
  • Integrity and judgment: applies governance rigor and risk management across HTA, pricing, and external engagements
Desirable Requirements
  • Direct negotiation experience on pricing and commercial agreements; experience with tender business
  • Experience managing external suppliers for modelling, evidence synthesis, and submission writing
  • Experience working with regional/local payers and systems (i.e. CCG, ICB) and translating national decisions to local adoption
  • Hands-on experienced with Excel/data handling and familiarity with health economics modelling workflows
  • Track record supporting new products planning and early access potential assessments for pipeline assets
  • Evidence of post-HTA implementation planning to achieve regional uptake in specialised services (e.g., pathway activation, service capacity solutions).
  • AI literacy: Experience using AI and developing AI solutions to streamline market access & pricing strategy, HTA deliverables and/or team leadership
  • Negotiation and commercial acumen: shapes pricing narratives, anticipates payer challenges, and supports tender strategy.
  • Analytical fluency: comfortable interrogating models, scenario analyses, and real-world evidence to inform strategy.
  • Future scanning: anticipates changes in HTA methodology, specialised commissioning, and policy; translates trends into proactive strategy.
  • Familiarity with international orphan policies (e.g., EU/EMA orphan frameworks) to inform UK/Ireland positioning and global alignment.
  • AI literacy: Experience using AI and developing AI solutions to streamline HTA development and submission processes.

When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.

Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Market Access Manager - Alexion - secondment/contract until 30.11.27
Senior Market Access Manager - Alexion - secondment/contract until 30.11.27

Alexion • Greater London

On-site
GBP 110,000 - 150,000
Excellent benefits
Senior Market Access Manager - Alexion - secondment/contract until 30.11.27
Senior Market Access Manager - Alexion - secondment/contract until 30.11.27

Alexion Pharmaceuticals, Inc. • Greater London

On-site
GBP 90,000 - 130,000
Market Access Director, UKMC
Market Access Director, UKMC

AstraZeneca • Greater London

On-site
GBP 140,000 - 190,000
Market Access Director, Ukmc
Market Access Director, Ukmc

AstraZeneca plc • Greater London

On-site
GBP 150,000 - 260,000
Medical Ethics Manager - Alexion
Medical Ethics Manager - Alexion

AstraZeneca plc • England

On-site
GBP 70,000 - 95,000
Health Economics Manager, Cvrm (9-Months Secondment/Ftc)
Health Economics Manager, Cvrm (9-Months Secondment/Ftc)

AstraZeneca plc • Greater London

Hybrid
GBP 70,000 - 100,000
Senior Market Access Lead - UK & Ireland (Rare Diseases)
Senior Market Access Lead - UK & Ireland (Rare Diseases)

Alexion Pharmaceuticals, Inc. • Greater London

On-site
GBP 90,000 - 130,000
Senior International Regulatory Affairs Director
Senior International Regulatory Affairs Director

AstraZeneca plc • Cambridge

On-site
GBP 150,000 - 210,000
Global exposure
Leadership role
Competitive compensation
Senior Director, Frontier Science - Early Infectious Disease
Senior Director, Frontier Science - Early Infectious Disease

AstraZeneca plc • Cambridge

On-site
GBP 140,000 - 210,000
Director, Technology Alliance Management (Alliance Lead)
Director, Technology Alliance Management (Alliance Lead)

AstraZeneca plc • Cambridge

On-site
GBP 140,000 - 180,000
Flexible benefits
Holiday purchase
Share Save Plans
+1